MedPath
FDA Approval

LIDOCAINE HCl

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Pearson Dental
DUNS: 082874108
Effective Date
May 15, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Lidocaine(20 mg in 1 mL)
Epinephrine(0.01 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Novocol Pharmaceutical of Canada, Inc.

Pearson Dental

Novocol Pharmaceutical of Canada, Inc.

201719960

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LIDOCAINE HCl

Product Details

NDC Product Code
43305-1030
Application Number
ANDA088390
Marketing Category
ANDA (C73584)
Route of Administration
SUBCUTANEOUS
Effective Date
May 15, 2012
LidocaineActive
Code: V13007Z41AClass: ACTIBQuantity: 20 mg in 1 mL
Code: 30Q7KI53AKClass: ACTIMQuantity: 0.01 mg in 1 mL
Potassium MetabisulfiteInactive
Code: 65OE787Q7WClass: IACTQuantity: 1.2 mg in 1 mL
Sodium ChlorideInactive
Code: 451W47IQ8XClass: IACTQuantity: 6.5 mg in 1 mL
Sodium HydroxideInactive
Code: 55X04QC32IClass: IACT
Edetate DisodiumInactive
Code: 7FLD91C86KClass: IACTQuantity: 0.25 mg in 1 mL
WaterInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath